Evidence map›Paper›PMID 41235391›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2025

Lorenzo Lippi, Alessio Turco, Girish H Rudrappa, Stefano Moalli, Alessandro de Sire, Marco Invernizzi

Abstract read
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Nutrients · 2026
    Trial
  2. International journal of molecular sciences · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lorenzo LippiDepartment of Health Sciences, University of Eastern Piedmont "A. Avogadro", Novara, Italy.
Alessio TurcoDepartment of Health Sciences, University of Eastern Piedmont "A. Avogadro", Novara, Italy.
Girish H RudrappaRajalakshmi Hospital & Research Center, Bangalore, India.
Stefano MoalliDepartment of Health Sciences, University of Eastern Piedmont "A. Avogadro", Novara, Italy.
Alessandro de SirePhysical Medicine and Rehabilitation Unit, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Marco InvernizziDepartment of Health Sciences, University of Eastern Piedmont "A. Avogadro", Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Concerns regarding the side effects of pharmacotherapy in the management of joint pain have led to increased interest in dietary supplements. Methods: A double-blind, randomized controlled trial was conducted with 90 adults (18-60 years of age) from Rajalakshmi Hospital and Research Center, Karnataka, India. Participants were randomly assigned to receive either 480 mg of AME ( Results: The AME group exhibited a significant 30% reduction in knee pain ( Discussion: AME was a safe and effective alternative for the management of knee joint pain and merits further longer-term investigation. Clinical Trial Registration: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=OTE3MTU=&Enc=&userName=, identifier CTRI/2023/09/057317.

Indexed as

Astragalus membranaceusdietary supplementsjoint painkneephytotherapyrehabilitation

Identifiers

PMID41235391
PMCPMC12605434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.